MENU
+Compare
RPTX
Stock ticker: NASDAQ
AS OF
Jun 27, 04:59 PM (EDT)
Price
$1.39
Change
-$0.02 (-1.42%)
Capitalization
59.62M

RPTX Repare Therapeutics Forecast, Technical & Fundamental Analysis

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RPTX with price predictions
Jun 26, 2025

RPTX's Stochastic Oscillator is sitting in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPTX advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

RPTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 149 cases where RPTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RPTX moved out of overbought territory on June 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RPTX as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RPTX turned negative on June 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.477) is normal, around the industry mean (16.566). P/E Ratio (0.000) is within average values for comparable stocks, (58.942). RPTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.298). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (54.945) is also within normal values, averaging (254.026).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RPTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RPTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RPTX is expected to report earnings to fall 21.13% to -56 cents per share on August 06

Repare Therapeutics RPTX Stock Earnings Reports
Q2'25
Est.
$-0.56
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.14
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -70 cents, missing the estimate of -62 cents. With 97.53K shares outstanding, the current market capitalization sits at 59.62M.
A.I. Advisor
published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LINK5.950.53
+9.78%
Interlink Electronics
WAL77.682.18
+2.89%
Western Alliance Bancorporation
BBU25.410.49
+1.97%
Brookfield Business Partners LPLimited Partnership Units
TTE61.560.52
+0.85%
TotalEnergies SE
MBX11.29-0.62
-5.21%
MBX Biosciences Inc.

RPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+2.92%
INO - RPTX
58%
Loosely correlated
+1.81%
BCYC - RPTX
51%
Loosely correlated
+2.54%
CADL - RPTX
43%
Loosely correlated
+3.71%
ALNY - RPTX
38%
Loosely correlated
-1.15%
AXON - RPTX
37%
Loosely correlated
+2.40%
More